Valeant To Participate At The 2018 Barclays Global Healthcare Conference

LAVAL, Quebec, March 8, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Barclays Global Healthcare Conference in Miami on March 14, 2018, at 8:30 a.m. EDT.

A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at: http://ir.valeant.com/events-and-presentations/2018.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-to-participate-at-the-2018-barclays-global-healthcare-conference-300609962.html

SOURCE Valeant Pharmaceuticals International, Inc.